Clinical Trials on Recurrent Urethral Urothelial Carcinoma
Total 2463 results
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Urothelial CarcinomaChina
-
The First Affiliated Hospital with Nanjing Medical...RecruitingBladder Urothelial CarcinomaChina
-
Sheba Medical CenterRecruiting
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
Lee's Pharmaceutical LimitedActive, not recruitingAdvanced Urothelial CarcinomaChina
-
National Taiwan University HospitalUnknownThe Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial CarcinomaBladder Urothelial CarcinomaTaiwan
-
Jinling Hospital, ChinaRecruitingCarcinoma | Upper Tract Urothelial Carcinoma | UTUCChina
-
Tata Memorial CentreNot yet recruitingNon-Invasive Bladder Urothelial Carcinoma
-
YULISUOno Pharmaceutical Co. LtdRecruitingUpper Urinary Tract Urothelial CarcinomaTaiwan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Head and Neck Carcinoma | Recurrent Skin Carcinoma | Recurrent Salivary Gland Carcinoma | Skin Squamous Cell CarcinomaUnited States
-
Southwest Hospital, ChinaUnknownHepatocellular Carcinoma RecurrentChina
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
Associació per a la Recerca Oncologica, SpainTakeda; Pivotal S.L.Unknown
-
National Cancer Institute (NCI)RecruitingMetastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Platinum-Resistant Urothelial CarcinomaUnited States
-
Associació per a la Recerca Oncologica, SpainPivotal S.L.; Merck, S.L., SpainCompletedMetastatic Urothelial CancerSpain
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
RenJi HospitalUnknown
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Urothelial CarcinomaChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
Tata Memorial HospitalUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astex Pharmaceuticals...CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRenal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
National Cancer Institute (NCI)TerminatedUrothelial CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedRecurrent Uterine Corpus CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); United States Department of DefenseRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMetastatic Urothelial CarcinomaChina
-
Shandong New Time Pharmaceutical Co., LTDUnknownLocally Advanced or Metastatic Urothelial Cell Carcinoma
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary | Recurrent Oral Cavity... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States